No abstract available
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Argininosuccinate Synthase / deficiency
-
Argininosuccinate Synthase / genetics
-
Argininosuccinate Synthase / metabolism*
-
Asbestos / adverse effects
-
Cisplatin / administration & dosage
-
Clinical Trials as Topic
-
DNA Methylation*
-
Fatal Outcome
-
Fluorodeoxyglucose F18*
-
Glutamates / administration & dosage
-
Guanine / administration & dosage
-
Guanine / analogs & derivatives
-
Humans
-
Hydrolases / therapeutic use*
-
Male
-
Mesothelioma / complications
-
Mesothelioma / diagnostic imaging
-
Mesothelioma / drug therapy*
-
Mesothelioma / enzymology*
-
Mesothelioma / etiology
-
Middle Aged
-
Mutation
-
Occupational Exposure / adverse effects
-
Pemetrexed
-
Pleural Effusion, Malignant / etiology
-
Pleural Neoplasms / complications
-
Pleural Neoplasms / diagnostic imaging
-
Pleural Neoplasms / drug therapy*
-
Pleural Neoplasms / enzymology*
-
Pleural Neoplasms / etiology
-
Polyethylene Glycols / therapeutic use*
-
Positron-Emission Tomography / methods*
-
Promoter Regions, Genetic*
-
Radiopharmaceuticals
Substances
-
Glutamates
-
Radiopharmaceuticals
-
Pemetrexed
-
Fluorodeoxyglucose F18
-
Asbestos
-
Polyethylene Glycols
-
Guanine
-
Hydrolases
-
ADI PEG20
-
Argininosuccinate Synthase
-
Cisplatin